Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.
Abstract
To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.
Overview
CoChat Summary
TL;DR
In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.
Key findings
- Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
- Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
- From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
- Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.
Methods
- Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
- Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
- Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.
Limitations
- The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
- The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
- Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted earlier, plasma epinephrine concentrations of this magnitude do occur during heavy exercise and absolute hypoglycemia, as well as during a variety of acute illnesses.”
What the sources say
- Not checked — no full text of the sourcecites [27] Galbo, H., J. J. Holst, and N. J. Christensen. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70–76. source
- Partly supportedcites [28] Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. 1976. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15. sourceExperimental — accuracy not yet measured
Our copy supports only the hypoglycemia limb of the claim: RESULTS p. 4 reports mean plasma epinephrine rising from 43±2 pg/ml to maximal levels of 2,200±660 pg/ml (50× basal) during insulin-induced hypoglycemia (plasma glucose 89±3 → 39±2 mg/dl, INTRODUCTION p. 1), i.e. concentrations far above 400 pg/ml in absolute hypoglycemia. The exercise and acute-illness limbs are not in our copy — METHODS p. 2 states subjects were maintained on absolute bed rest, and no passage reports epinephrine during heavy exercise or during acute illness; the DISCUSSION (p. 6) instead closes by saying a role for adrenergic mechanisms in 'more physiologic fluctuations' of plasma glucose 'remains to be established.' Searched: exercise/physical exertion, acute illness/stress, epinephrine >400 pg/ml. (LLM, conf=0.75)
- Not matchedcites [30]
The reference list we hold has no entry [30].
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose clearance declined and remained suppressed during the infusion of epinephrine at the higher infusion rates”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose utilization did not change”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but lower for increments in blood glycerol, 75–125 pg/ml”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“As noted previously (25), glucose production rose transiently, returning to near base line by 60 min”
What the sources say
- Not checked — no full text of the sourcecites [25] Rizza, R. A., M. W. Haymond, P. E. Cryer, and J. E. Gerich. 1979. Differential effects of physiologic concentrations of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237: E356–E362. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 47 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“plasma epinephrine concentrations do not commonly achieve the threshold level required to affect basal glucose metabolism (7).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a more than eightfold increase in mean plasma epinephrine to a level known to have hyperglycemic effects in man (38).”
From Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (1984) · cites this paper as [38]
Citations
Cites
Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., & Schulz, D. W. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51740-3 · Cited by 2,221
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Self-citationHormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose
Bier, D. M., Leake, R. D., Haymond, M. W., Arnold, K. J., Gruenke, L. D., Sperling, M. A., & Kipnis, D. M. (1977) · Diabetes · doi:10.2337/diab.26.11.1016 · Cited by 444
Self-citationGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
Immunoassay of Insulin Using a Two-Antibody System.
Morgan, C. R., & Lazarow, A. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-110-27411 · Cited by 367
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationDetermination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 344
Cited by
Items 201–300 of 577
Riles, T. S., Fisher, F. S., Schaefer, S., et al. (1993) · Annals of Vascular Surgery · doi:10.1007/bf02000244 · Cited by 37
Catecholamine release during and after cross clamping of descending thoracic aorta
Normann, N. A., Taylor, A. A., Crawford, E. S., et al. (1983) · Journal of Surgical Research · doi:10.1016/0022-4804(83)90047-1 · Cited by 37
Severe Lactic Acidosis as a Presenting Feature of Pheochromocytoma
Madias, N. E., Goorno, W. E., & Herson, S. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80182-8 · Cited by 39
Maron, M. B. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.5.1702 · Cited by 37
“(6), who observed a linear relationship between epinephrine infusion rate and steady-state plasma epinephrine concentration in humans and that, at a given infusion rate, plasma epinephrine concentration remained constant once steady-state values had been achieved.”
BackgroundThe effects of epinephrine on norepinephrine release in essential hypertension.
Nezu, M., Miura, Y., Adachi, M., Adachi, M., Kimura, S., TORIYABE, S., Ishizuka, Y., Ohashi, H., Sugawara, T., & Takahashi, M. (1985) · Hypertension · doi:10.1161/01.hyp.7.2.187 · Cited by 42
Desensitization of the nicotinic secretory response of adrenal chromaffin cells
Marley, P. D. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90177-0 · Cited by 37
Epinephrine Deficiency in Hypocorticotropic Hypopituitary Children*
RUDMAN, D., MOFFITT, S. D., FERNHOFF, P. M., BLACKSTON, R. D., & FARAJ, B. A. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-4-722 · Cited by 37
Modeling the metabolic effects of terbutaline in ?2-adrenergic receptor diplotypes*1
Lima, J. J., Matsushima, N., Kissoon, N., Wang, J., Sylvester, J. E., & Jusko, W. J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.006 · Cited by 37
ENSINGER, H., Träger, K., Geisser, W., Anhäupl, T., Ahnefeld, F. W., Vogt, J. A., & Georgieff, M. (1994) · Intensive Care Medicine · doi:10.1007/bf01707665 · Cited by 35
“05 ~tg/kg/min causes a transient increase in the hepatic glucose production and a persistent decrease in the plasma glucose clearance [5, 6].”
BackgroundGlucose metabolism in children during the first day after burn injury.
Childs, C., Heath, D. F., Little, R., & Brotherston, M. (1990) · Emergency Medicine Journal · doi:10.1136/emj.7.3.135 · Cited by 36
Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.
Boyle, P. J., Liggett, S. B., Shah, S. D., & Cryer, P. E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113617 · Cited by 36
Self-citationAdrenergic blockade does not abolish elevated glucose turnover during bacterial infection
Hargrove, D. M., Bagby, G. J., Lang, C. H., & Spitzer, J. J. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.1.e16 · Cited by 43
Hormonal control of ketone body metabolism in the normal and diabetic state.
Johnston, D. G., & Alberti, K. G. M. M. (1982) · PubMed · Cited by 38
Segal, J., & Ingbar, S. H. (1980) · Endocrinology · doi:10.1210/endo-107-5-1354 · Cited by 35
Diabetic ketoacidosis in a case of pheochromocytoma
Ishii, C., lnoue, K., Negishi, K., 太根, 伸., Awata, T., & Katayama, S. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00261-3 · Cited by 34
Reversal of antiarrhythmic drug effects by epinephrine: Quinidine versus amiodarone
Calkins, H. G., de Sousa, J., Rafel Atassi, E. L., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90490-e · Cited by 34
Metabolic actions of catecholamines in man
Webber, J., & Macdonald, I. A. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80181-8 · Cited by 38
Opioid peptides and metabolic regulation
Giugliano, D., Torella, R., Lefèbvre, P. J., & D'Onofrio, F. (1988) · Diabetologia · doi:10.1007/bf00279126 · Cited by 34
“Early studies showing stimulation of glucagon secretion in man by high physiological epinephrine doses have been recently disputed [129, 130 ].”
BackgroundPatients with Type 1 Diabetes Adapt Acutely to Sustained Mild Hypoglycaemia
Kerr, D., Macdonald, I. A., & Tattersall, R. B. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01557.x · Cited by 34
Frequency and amplitude enhancement of calcium transients by cyclic AMP in hepatocytes
Schöfl, C., Sanchez-Bueno, A., Brabant, G. E., et al. (1991) · Biochemical Journal · doi:10.1042/bj2730799 · Cited by 34
Functions Mediated by alpha-2 Adrenergic Receptors
Ruffolo, R. R., Jr., Nichols, A. J., & Hieble, J. P. (1988) · The Receptors · doi:10.1007/978-1-4612-4596-4_5 · Cited by 41
Quantitative Assessment of Blood Lactate in Shock: Measure of Hypoxia or Beneficial Energy Source
Levitt, D. G., Levitt, J. E., & Levitt, M. D. (2020) · BioMed Research International · doi:10.1155/2020/2608318 · Cited by 41
Exercise‐induced increments in plasma levels of propranolol and noradrenaline.
Hurwitz, G. A., Webb, J., Walle, T., Bai, S., Daniell, H. B., Gourley, L. A., Loadholt, B. C., & Gaffney, T. E. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02228.x · Cited by 36
Gluconeogenesis and hypoglycemia
Frizzell, R. T., Campbell, P. J., & Cherrington, A. D. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040107 · Cited by 34
Norepinephrine Infusion during Moderate-Intensity Exercise Increases Glucose Production and Uptake1
Kreisman, S. H., Ah Mew, N., Halter, J. B., Vranic, M., & Marliss, E. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7476 · Cited by 33
Effects of Increased Arterial Epinephrine on Insulin, Glucose and Phosphate
Kjeldsen, S. E., Moan, A., Pétrin, J., Weder, A. B., & Julius, S. (1996) · Blood Pressure · doi:10.3109/08037059609062103 · Cited by 32
Advances in biochemical screening for phaeochromocytoma using biogenic amines.
Whiting, M. J., & Doogue, M. P. (2009) · PubMed · Cited by 44
Altered cardiovascular and neurohumoral responses to head-up tilt after heart-lung transplantation.
Banner, N. R., Williams, T. D. M., Patel, N., Chalmers, J. A. C., Lightman, S. L., & Yacoub, M. H. (1990) · Circulation · doi:10.1161/01.cir.82.3.863 · Cited by 31
Plasma catecholamines in the acute phase of the response to myocardial infarction.
Little, R., Frayn, K. N., Randall, P. E., Stoner, H. B., Morton, C., Yates, D., & Laing, G. S. (1986) · Emergency Medicine Journal · doi:10.1136/emj.3.1.20 · Cited by 32
The Effect of Repetitive Exercise on Airway Temperatures
Gilbert, I., Fouke, J. M., McFadden, E. R., & With the technical assistance of K. A. Lenner and A. J. Coreno, Jr. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.4.826 · Cited by 31
Krumeich, L. N., Cucchiara, A. J., Nathanson, K. L., Kelz, R. R., Fishbein, L. M., Fraker, D. L., Roses, R. E., Cohen, D. L., & Wachtel, H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab401 · Cited by 34
Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects
Joyce, P. R., Nicholls, M. G., & Donald, R. A. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90568-x · Cited by 31
Meechan, J. G., & Rawlins, M. D. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609962 · Cited by 31
“adrenaline concentration at 5min and, although Clutter et al. (1980) claim that such an increase is sufficient to produce cardiac effects, Tolas et al. found the influence on haemodynamic response to be small and not statistically significant. Vemale (1960) claimed that the cardiovascular responses did not differ betw…”
BackgroundInfluentialBerkin, K. E., Walker, G., Inglis, G. C., Ball, S. G., & Thomson, N. C. (1988) · Thorax · doi:10.1136/thx.43.4.295 · Cited by 31
Evaluation of the Dopamine Response to Stress in Man*
Woolf, P. D., AKOWUAH, E. S., Lee, L. A., Kelly, M. M., & Feibel, J. H. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-2-246 · Cited by 32
Identification and characterisation of β-adrenoceptors in guinea-pig skeletal muscle
Elfellah, M. S., & Reid, J. L. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90498-5 · Cited by 31
Presynaptic Receptors on Catecholamine Neurones
Langer, S. Z., & Lehmann, J. C. (1988) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-46625-0_8 · Cited by 36
Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs
Martin, I. K., Weber, K. M., Boston, R. C., ALFORD, F. P., & Best, J. D. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.5.e668 · Cited by 30
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism
Castellino, P., Luzi, L., Prato, S. D., & DeFronzo, R. A. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e117 · Cited by 30
Kraenzlin, M., Keller, U. B., Keller, A., Thélin, A., Arnaud, M. J., & Stauffacher, W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114178 · Cited by 32
Adrenaline Auto‐Injectors for Preventing Fatal Anaphylaxis
Sim, M., Sharma, V., Li, K., Gowland, M. H., Garcez, T. P., Shilladay, C., Pumphrey, R. S. H., Patel, N., Turner, P., & Boyle, R. J. (2024) · Clinical & Experimental Allergy · doi:10.1111/cea.14565 · Cited by 32
Nutrition delivery of a model-based ICU glycaemic control system
Stewart, K. W., Chase, J. G., Pretty, C. G., & Shaw, G. M. (2018) · Annals of Intensive Care · doi:10.1186/s13613-017-0351-9 · Cited by 29
“Background The ICU patient is under considerable physiological stress, resulting in 20–40% of patients experiencing dysregulation of blood glucose (BG) levels [1] and hyperglycaemia [2, 3], which is associated with increased morbidity and mortality [4–6].”
BackgroundOualha, M., Urien, S., Spreux‐Varoquaux, O., Bordessoule, A., D’Agostino, I., Pouard, P., & Tréluyer, J. (2014) · Critical Care · doi:10.1186/cc13707 · Cited by 31
“A one-compartment open model with linear elimination adequately described the data as previously reported [3,5,19].”
MethodMj, B., & Dollery, C. T. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409062582 · Cited by 34
Hosoda, R., HATTORI, M., & Shimada, Y. (1993) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1993.tb03748.x · Cited by 28
Boyle, P. J., Avogaro, A., Smith, I., SHAH, S. D., Cryer, P. E., & Santiago, J. V. (1992) · Diabetologia · doi:10.1007/bf00401205 · Cited by 27
“Plasma for glucose radioactivity was precipitated with perchloracetic acid and the supernatant decanted, dried and reconstituted in distilled water prior to scintillation counting; glucose production and utilization rates were calculated as described previously [22].”
MethodSelf-citationDiagnostic and prognostic use of L ‐lactate measurement in equine practice
Henderson, I. S. F. (2013) · Equine Veterinary Education · doi:10.1111/eve.12033 · Cited by 28
“An increase in circulating adrenaline in various disease states is associated with hyperlactataemia (Clutter et al. 1980; McCarter et al. 2001).”
BackgroundKong, K. L., Willatts, S. M., Prys-Roberts, C., et al. (1990) · Intensive Care Medicine · doi:10.1007/bf01724797 · Cited by 28
“APACHE II scores of 13, have high circulating adrenaline and noradrenaline concentrations, 12- 30 times those seen in normal supine subjects at rest [11, 12].”
BackgroundFunctional maturation of the adrenal medulla and peripheral sympathetic nervous system.
Padbury, J. F. (1989) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(89)80049-7 · Cited by 28
Horowitz, J. F., Braudy, R. J., Martin, W. H., & Klein, S. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.2.e325 · Cited by 28
“The hormonal clamp technique (17) was used to prevent epinephrine-induced hyperinsulinemia (4) and to avoid possible training-induced alterations in plasma insulin concentration.”
MethodPlasma glucagon and catecholamines during exhaustive short-term exercise
N�veri, H., Kuoppasalmi, K. I., & H�rk�nen, M. (1985) · European Journal of Applied Physiology · doi:10.1007/bf00422844 · Cited by 35
“The catecholamine concentrations in plasma were in both cases so high that both circulating adrenaline and noradrenaline could have stimulated liver glucose production (Silverberg et al. 1978; Clutter et al. 1980).”
BackgroundChu, C. A., Galassetti, P. R., Igawa, K., Sindelar, D. K., Neal, D. W., Burish, M. J., & Cherrington, A. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00565.2001 · Cited by 28
Smoking and insulin sensitivity in type I diabetic patients
Helve, E., Yki‐Järvinen, H., & Koivisto, V. A. (1986) · Metabolism · doi:10.1016/0026-0495(86)90231-3 · Cited by 28
Hormonal and cardiovascular variations during a public lecture
Bolm‐Audorff, U., Schw�mmle, J., Ehlenz, K., Koop, H., & Kaffarnik, H. (1986) · European Journal of Applied Physiology · doi:10.1007/bf00943358 · Cited by 27
Corssmit, E. P. M., Stouthard, J. M., Romijn, J. A., Endert, E., & Sauerwein, H. P. (1994) · Metabolism · doi:10.1016/0026-0495(94)90008-6 · Cited by 30
Regulation of Carbohydrate Metabolism and Response to Hypoglycemia
Butler, P. C., & Rizza, R. A. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30386-4 · Cited by 30
Bansal, S., Lee, L. A., & Woolf, P. D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-2-301 · Cited by 27
Macdonald, I. A., Bennett, T. M., Brown, A., Wilcox, R., & Skene, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02343.x · Cited by 28
The impact of body composition on the regulation of lipolysis during short-term fasting.
Klein, S., Young, V. R., Blackburn, G. L., Bistrian, B. R., & Wolfe, R. R. (1988) · Journal of the American College of Nutrition · doi:10.1080/07315724.1988.10720223 · Cited by 27
Hormonal Regulation of Protein Metabolism
Long, C. L., & Lowry, S. F. (1990) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607190014006555 · Cited by 27
Effects of exercise intensity and duration on fat metabolism in trained and untrained older males
Bassami, M., Ahmadizad, S., Doran, D. A., & MacLaren, D. P. M. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0523-7 · Cited by 33
“Greater relative exercise intensities are likely associated with enhanced CHO oxidation, regardless of nutritional state, because of likely increased recruitment of type II CHO-dependent fibers and increased catecholamine concentration (Clutter et al. 1980).”
BackgroundChanges in cardiac transcapillary exchange with metabolic coronary vasodilation in the intact dog.
Cousineau, D., Rose, C. P., Lamoureux, D., et al. (1983) · Circulation Research · doi:10.1161/01.res.53.6.719 · Cited by 26
Regulation of glucose production during exercise at 80% of VO2peak in untrained humans
Coggan, A. R., Raguso, C. A., Gastaldelli, A., Williams, B. D., & Wolfe, R. R. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e348 · Cited by 26
3 Hormonal control of ketone body metabolism in the normal and diabetic state
Johnston, D. G., & Alberti, K. G. M. M. (1982) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(82)80019-4 · Cited by 28
The effects of epinephrine in local anesthetics on plasma catecholamine and hemodynamic responses
Takahashi, Y., Nakano, M., Sano, K., et al. (2005) · Odontology · doi:10.1007/s10266-005-0044-y · Cited by 25
Kämmerer, P. W., Seeling, J., Alshihri, A. A., et al. (2013) · Clinical Oral Investigations · doi:10.1007/s00784-013-1010-7 · Cited by 25
“Therefore, for older and medically compromised patients, special care when using higher concentrations of epinephrine is recommended [39, 40, 43].”
BackgroundDelayed extra-adrenal epinephrine secretion after bilateral adrenalectomy in rats
Ricordi, C., SHAH, S. D., Lacy, P. E., Clutter, W. E., & Cryer, P. E. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.1.e52 · Cited by 33
Self-citationEffects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.
Al‐Damluji, S., & REES, L. H. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.1098 · Cited by 27
Buijs, M. M., Burggraaf, J., Wijbrandts, C. A., de Kam, M. L., Frölich, M., Cohen, A. F., Romijn, J. A., Sauerwein, H. P., Meinders, A. E., & Pijl, H. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.544 · Cited by 27
“Plasma catecholamines per se do not reach the threshold concentrations that are necessary to stimulate lipolysis during a short-term fast in humans (28, 33).”
BackgroundDifferential effects of defibrillation on systemic and cardiac sympathetic activity
Bode, F., WIEGAND, U. K. H., Raasch, W., Richardt, G., & Potratz, J. (1998) · Heart · doi:10.1136/hrt.79.6.560 · Cited by 26
Marker, J. C., Cryer, P. E., & Clutter, W. E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.3.e380 · Cited by 25
Self-citationCardiovascular Fitness and Selected Adrenal Hormone Responses to Cognitive Stress
Sothmann, M. S., Gustafson, A. B., Garthwaite, T. L., Horn, T. S., & Hart, B. A. (1988) · Endocrine Research · doi:10.3109/07435808809036340 · Cited by 25
Musgrave, I., Bachmann, A. W., Jackson, R. V., et al. (1985) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1985.tb02647.x · Cited by 25
Decreased plasma epinephrine concentrations after glucose ingestion in humans
Trunet, P. F., Lhoste, F., Ansquer, J.-C., Kestenbaum, S., Sabatier, C., Tillement, J. P., & RAPIN, M. (1984) · Metabolism · doi:10.1016/0026-0495(84)90118-5 · Cited by 24
Renal contribution to plasma catecholamines--effect of age.
Kjeldsen, S. E., Eide, I. A., Christensen, C., et al. (1982) · PubMed · Cited by 24
Morady, F., Kou, W. H., Kadish, A. H., et al. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90659-5 · Cited by 24
Defective glucose counterregulation limits intensive therapy of diabetes mellitus
Santiago, J. V., White, N. H., Skor, D. A., Levandoski, L. A., Bier, D. M., & Cryer, P. E. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e215 · Cited by 31
Self-citationThe Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Self-citationEffect of diabetes on serum potassium concentrations in acute coronary syndromes
Foo, K., Sekhri, N., Deaner, A., Knight, C. J., Suliman, A., Ranjadayalan, K., & Timmis, A. (2002) · Heart · doi:10.1136/heart.89.1.31 · Cited by 23
Caspi, J., Coles, J. G., Benson, L. N., et al. (1993) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33848-6 · Cited by 23
Dierkx, R., VANDEHOEK, W., Hoekstra, J. B. L., & Erkelens, D. W. (1996) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(96)80018-0 · Cited by 29
Insulin and Forearm Vasodilation in Hypertension-Prone Men
Hulthén, U. L., Endre, T., Mattiasson, I., & Berglund, G. L. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.214 · Cited by 23
Maslov, M. Y., Edelman, E. R., Wei, A. E., Pezone, M. J., & Lovich, M. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.038 · Cited by 22
“For these reasons, epinephrine, a drug with well described systemic pharmacokinetics [15], was administered to a focal region of the epicardial surface of the anterior wall of the rat heart in a preparation that measures indices of global left ventricular (LV) contractility in real time, and tissue levels of drug and…”
BackgroundHyperglycemia in the acute phase of stroke and stress response.
Tracey, F., & Stout, R. W. (1994) · Stroke · doi:10.1161/01.str.25.2.524 · Cited by 21
Avogaro, A., Valerio, A., Gnudi, L., Maran, A., Miola, M., Duner, E., Marescotti, C., Iori, E., Tiengo, A., & Nosadini, R. (1992) · Diabetologia · doi:10.1007/bf00402544 · Cited by 21
Krakoff, L. R., Dziedzic, S. W., Mann, S. J., Felton, K., & Yeager, K. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80058-9 · Cited by 22
Epinephrine infusion induces hyporesponsiveness of vascular smooth muscle
Maze, M., Spiss, C. K., Tsujimoto, G., et al. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90475-8 · Cited by 22
Catecholamines and essential hypertension
Esler, M. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80182-x · Cited by 22
Chen, M., HALTERIN, J. B., & Porte, D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1193 · Cited by 22
Raju, B., & Cryer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00188.2004 · Cited by 22
“which can increase plasma glucose and serum nonesterified concentrations rapidly ( 5 ), were”
BackgroundSelf-citationAttvall, S., Fowelin, J., von Schenck, H., Lager, I., & Smith, U. (1987) · Diabetologia · doi:10.1007/bf00296990 · Cited by 23
Ludwig, J. D. C., Halbr�gge, T., Vey, G., Walter, J., & Graefe, K. ‐. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558130 · Cited by 21
“…sympathetic tone Evidence in man clearly indicates that the apparent clearance of infused catecholamines from arterial or peripheral venous plasma is dependent on cardiac output (Clutter et al. 1980; Best and Halter 1982; Brown et al. t982; Esler 1982; Hasking et al. 1986; Ziegler et al. 1986).”
BackgroundBerndt, N., Eckstein, J., Wallach, I., Nordmeyer, S., Kelm, M., Kirchner, M., Goubergrits, L., Schafstedde, M., Hennemuth, A., Kraus, M., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055646 · Cited by 26
Petrák, O., Klímová, J., Mráz, M., Haluzíková, D., Doležalová, R., Kratochvílová, H., Lacinová, Z., Novák, K., Michalský, D., Waldauf, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa154 · Cited by 24
Hemodynamic Reactivity to Sympathoadrenal Stimulation in Adrenalectomized Women*
Lenders, J. W. M., Peters, J. H., PIETERS, G. F. F. M., Willemsen, J. J., & Thien, T. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-139 · Cited by 21
Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia
Paramore, D. S., Fanelli, C. G., Shah, S. D., & Cryer, P. E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e872 · Cited by 21
“(from 240 6 40 to 340 6 50 pmol/l); the stimulated levels were probably not high enough to exert biological effects (12, 13).”
BackgroundSelf-citationThe Dawn Phenomenon Does Not Occur in Normal Elderly Subjects*
Meneilly, G. S., Elahi, D., Minaker, K. L., & Rowe, J. W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-292 · Cited by 21
Scheeren, T., & Arndt, J. O. (2000) · Critical Care Medicine · doi:10.1097/00003246-200012000-00021 · Cited by 21
Stokes, P. E., Maas, J. W., Davis, J. M., Koslow, S. H., Casper, R. C., & Stoll, P. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.868 · Cited by 22
Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension
Kjeldsen, S. E., Eide, I. A., Aakesson, I., & Leren, P. (1983) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518309168269 · Cited by 22
Metadata
- Authors
- Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Bier, D M
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371510
- OpenAlex
- W2133884882
- Cited by
- 576
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.